Friday, December 7, 2012

• Important Catalysts For 3 Biotech Companiesat Seeking Alpha (Fri, Dec 7)

Tuesday, December 4, 2012

• Why Amicus Therapeutics Is Poised to Plungeat Motley Fool (Tue, Dec 4)
• 7 Low-Price Biotechs With High Positive Equityat Seeking Alpha (Tue, Dec 4)
• Amicus: Bullish Options Trade Into Clinical Trial Catalystsat TheStreet (Tue, Dec 4)

Friday, November 30, 2012

• 3 Humongous Health-Care Stocks This Weekat Motley Fool (Fri, Nov 30)
• Biotech Stock Mailbag: Amicus, Celldexat TheStreet (Fri, Nov 30)
• Friday's Small Cap Biopharma Catalyst Trade And Speculation Investment Listat Seeking Alpha (Fri, Nov 30)

Wednesday, November 28, 2012

• Best Biotechnology and Pharmaceutical Investing Interviews of 2012: Oncology Treatments Expert Analyst Details his MethodologyWall Street Transcript (Wed, Nov 28)
• Glaxo Invests in NigeriaZacks (Wed, Nov 28)

Tuesday, November 27, 2012

• 4 Biotech Stocks Under $10 Moving Higherat TheStreet (Tue, Nov 27)
• Glaxo to Expand in IndiaZacks (Tue, Nov 27)

Friday, November 23, 2012

• FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011Marketwired (Fri, Nov 23)

Tuesday, November 20, 2012

• Biopharmaceutical Stocks: Possible Catalysts in November (Part 2)at Motley Fool (Tue, Nov 20)
• Glaxo's Promacta Label ExpandedZacks (Tue, Nov 20)

Sunday, November 18, 2012

• Finding A Cure For Parkinson'sat Seeking Alpha (Sun, Nov 18)

Thursday, November 15, 2012

• Amicus Therapeutics' Management Discusses at Lazard Capital Markets Healthcare Conference (Transcript)at Seeking Alpha (Thu, Nov 15)

Tuesday, November 13, 2012

• These 5 Insider Favorites Are Trading At Big Discounts To Target Priceat Seeking Alpha (Tue, Nov 13)

Friday, November 9, 2012

• 5 Biotech Stocks To Go Long Nowat Seeking Alpha (Fri, Nov 9)

Thursday, November 8, 2012

• Amicus Therapeutics Poised For Rebound Into December Phase III Resultsat Seeking Alpha (Thu, Nov 8)

Tuesday, November 6, 2012

• AMICUS THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Nov 6)
• Amicus' CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Nov 6)

Monday, November 5, 2012

• AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EEDGAR Online (Mon, Nov 5)

Thursday, November 1, 2012

• Comverse Initiated at Hold and 1 Analyst-Initiated Share on the Moveat Wall St. Cheat Sheet (Thu, Nov 1)
• Glaxo Misses on Both CountsZacks (Thu, Nov 1)

Thursday, October 25, 2012

• FDA Considering Allowing Developers of Critical Drugs/Treatments to Conduct Smaller, Faster Clinical TrialsMarketwired (Thu, Oct 25)

Add FOLD News to My Yahoo!